Search research articles
Contact Us
Filters
Showing results (121-130 of 177) with videos related to
Page
of 18
Sort By:
Medicine
|
June 15, 2018
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)
Jessica Mandrioli, Roberto D'Amico, Elisabetta Zucchi, et al.
Environmental Research
|
April 27, 2020
Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study
Maria Fiore, Roberto Parisio, Tommaso Filippini, et al.
International Journal of Environmental Research and Public Health
|
February 6, 2020
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study
Tommaso Filippini, Maria Fiore, Marina Tesauro, et al.
International Journal of Environmental Research and Public Health
|
September 10, 2020
Reply to Comment on "Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study"
Tommaso Filippini, Marina Tesauro, Maria Fiore, et al.
International Journal of Environmental Research and Public Health
|
April 26, 2020
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study
Tommaso Filippini, Marina Tesauro, Maria Fiore, et al.
Annals of Neurology
|
April 26, 2025
Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis
Rosario Vasta, Emanuele Koumantakis, Antonio Canosa, et al.
BMJ Open
|
June 2, 2019
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)
Jessica Mandrioli, Valeria Crippa, Cristina Cereda, et al.
Neuron
|
March 19, 2013
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels
Fernando Bartolome, Hsiu-Chuan Wu, Victoria S Burchell, et al.
Journal of Neurology
|
October 24, 2022
Factors predicting disease progression in C9ORF72 ALS patients
Jessica Mandrioli, Elisabetta Zucchi, Ilaria Martinelli, et al.
Population Health Metrics
|
July 31, 2025
Patient-centred estimation of multimorbidity in chronic disease populations: a novel approach integrating global burden of disease metrics and healthcare administrative data
Daniela Fortuna, Luana Caselli, Michele Romoli, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 177) with videos related to
Sort By:
Page
of 18
Medicine
|
June 15, 2018
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)
Jessica Mandrioli, Roberto D'Amico, Elisabetta Zucchi, et al.
Environmental Research
|
April 27, 2020
Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study
Maria Fiore, Roberto Parisio, Tommaso Filippini, et al.
International Journal of Environmental Research and Public Health
|
February 6, 2020
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study
Tommaso Filippini, Maria Fiore, Marina Tesauro, et al.
International Journal of Environmental Research and Public Health
|
September 10, 2020
Reply to Comment on "Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study"
Tommaso Filippini, Marina Tesauro, Maria Fiore, et al.
International Journal of Environmental Research and Public Health
|
April 26, 2020
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study
Tommaso Filippini, Marina Tesauro, Maria Fiore, et al.
Annals of Neurology
|
April 26, 2025
Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis
Rosario Vasta, Emanuele Koumantakis, Antonio Canosa, et al.
BMJ Open
|
June 2, 2019
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)
Jessica Mandrioli, Valeria Crippa, Cristina Cereda, et al.
Neuron
|
March 19, 2013
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels
Fernando Bartolome, Hsiu-Chuan Wu, Victoria S Burchell, et al.
Journal of Neurology
|
October 24, 2022
Factors predicting disease progression in C9ORF72 ALS patients
Jessica Mandrioli, Elisabetta Zucchi, Ilaria Martinelli, et al.
Population Health Metrics
|
July 31, 2025
Patient-centred estimation of multimorbidity in chronic disease populations: a novel approach integrating global burden of disease metrics and healthcare administrative data
Daniela Fortuna, Luana Caselli, Michele Romoli, et al.
Page
of 18